Our anti-sepsis therapeutics division has created multiple small peptides that have been engineered to neutralize LPS (Endotoxin). Kdeon™ peptides have high binding affinity for LPS and are capable of inhibiting attachment of LPS to CD-14 on endothelial cells, T cells, and macrophages.  Blockade or interference with the LPS:CD-14 interaction should limit the downstream effects resulting from … Continue reading KDEON (TM)